Initiate Ventures & Studios
Jessica is a co-founder of Initiate Studio, a innovation platform creating digitally-enabled life sciences, diagnostics, and healthcare companies.
Jessica was a co-founder of GRAIL, Inc. a healthcare company who's mission is to detect cancer early, when it can be cured. After founding the company, Jessica built and led the commercial organization. GRAIL is being acquired by Illumina, Inc for $8BN.
Previously, Jessica was an Entrepreneur in Residence at Versant Ventures and CEO of Acumen, digital health startup enabling patients and physicians to better manage chronic neurological disorders through the capture and analysis of patient video.
Prior to joining Versant, Jessica worked in Corporate Strategy and Business Development at Genomic Health, a molecular diagnostics company that provides genomic analysis to aid in the selection cancer treatments.
Earlier, Jessica was a partner in the life sciences practice at Kleiner, Perkins, Caufield and Byers. She also worked in Finance for Genentech, was an equity research analyst at Thomas Weisel Partners, and was an investment banking analyst in biotechnology at Robertson Stephens. She began her career in biomedical research at the Centers for Disease Control and Prevention in the Special Pathogens Branch.
Education, Personal, and Fellowship
Jessica received an MBA from Harvard Business School, an MS from the Department of Cancer Biology at Stanford University, and a BA in Biology from Agnes Scott College where she was Phi Beta Kappa. She now serves as a Trustee to Agnes Scott.
Jessica is a member of Kauffman Fellows Class 12. She served her fellowship at Kleiner Perkins Caufield & Byers under mentor Risa Stack (Class 2).